awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30239781-3084857D-1549-42C1-8D13-3079B8C43679
Q30239781-3084857D-1549-42C1-8D13-3079B8C43679
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30239781-3084857D-1549-42C1-8D13-3079B8C43679
A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survival.
P2860
Q30239781-3084857D-1549-42C1-8D13-3079B8C43679
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30239781-3084857D-1549-42C1-8D13-3079B8C43679
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6b9554fb984104fc3f6ec2d774be82751e624076
P2860
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK